E
Entera Bio Ltd. (ENTX)
NCM – Real Time Price. Currency in USD
1.25
+0.08 (6.84%)
At close: May 12, 2026, 4:00 PM EDT
1.28
+0.03 (2.40%)
After-hours: May 12, 2026, 6:47 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
1.25
+0.08 (6.84%)
At close: May 12, 2026, 4:00 PM EDT
1.28
+0.03 (2.40%)
After-hours: May 12, 2026, 6:47 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 6.94 | 6.05 | 10 | |
| Quick ratio | 6.94 | 5.63 | 10 | |
| Debt to Equity | 0.04 | 0.30 | 9.0 | |
| Debt to Assets | 0.03 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 134K | N/A | 181K | 42K | 42K |
| Gross Profit | -31K | -56K | 9K | -30K | -22K |
| Operating Income | -13M | -9M | -10M | -12M | -12M |
| Net Income | -13M | -9M | -10M | -11M | -11M |
| EBITDA | -13M | -9M | -10M | -11M | -11M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 100 | -33.33 | 5.5 |
| Next quarter | N/A | -50 | 1.0 |
| Current year | -100 | -68 | 1.0 |
| Next year | N/A | -35.71 | 1.0 |
| Weighted average score | 2.1 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 5.75 | 14.29 | 26.23 | 8.3 |
| Y/Y | -99.99 | -27.9 | 0 | -38.03 | 1.0 |
| 3y average | 274.07 | 1.6 | 16.82 | 12.97 | 7.5 |
| 5y average | 160.43 | -2.21 | -26.13 | 3.03 | 4.0 |
| Weighted average score | 5.2 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $14.9M significantly exceed its total debt $490.0K, ensuring strong financial flexibility
Total current assets $15.3M exceed Total current liabilities $2.2M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$2.1M limits the company's ability to reinvest or pay down debt